Biotage
Presence
Biotage is a company listed under the stock ticker BIOT (SE).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Biotage
- Torben Jorgensen, Interim Chief Executive Officer and Director
- Dan Menasco, Director, Employee Representative
- Pär Lundgren, Director, Employee Representative
Popular executive movements at Biotage
- Torben Jorgensen, who was Chairman of the Board, is promoted to Interim Chief Executive Officer and Chairman of the Board (posted on January 5 2024).
- Tomas Blomquist, Chief Executive Officer and President, has left the company (posted on January 5 2024).
- Andrew Kellett has joined the company as Interim Chief Financial Officer (posted on September 11 2023).
Create your alert
to follow the executive moves at Biotage.
Biotechnology
Biotage has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Biotage
- Biotage News
- Press Releases
- Biotage® PRESSURE+
- Press Releases
- Biotage AB (publ) Interim report January-September 2020 - Biotage
- Biotage’s Board of Directors does not intend to propose a dividend during the current year - Biotage
- Biotage - Pressmeddelanden
- Biotage - Login
- Biotage - Press Releases
- Biotage - Login
- View more press releases Close
Social media about Biotage
- Biotage on Wikipedia, Google News & Yahoo Finance
- Biotage on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Dan Menasco 
